Lupin Archives - Express Pharma

Lupin receives FDA approval for generic version of Adderall XR

Lupin launches Bumetanide injection USP in the United States

Lupin launches Humrahi with focus on diabetes and heart health

Lupin receives tentative U.S. FDA approval for Raltegravir tablets

The quest for quality continues

Lupin to focus on development of inhalers with near-zero global warming potential propellants

Lupin appoints Claus Jepsen as President of Global Specialty

Lupin launches first generic of Pred Forte in the US

Lupin acquires nine brands of Medical Nutritional Institute in South Africa

Lupin signs distribution agreement with scope Ophthalmics for eye care products in Mexico